Abstract:Niemann-Pick disease type C1 (NPC1) is a fatal congenital neurodegenerative disorder caused by mutations in the NPC1 gene, which is involved in cholesterol transport in lysosomes. Broad clinical manifestations of NPC1 include liver failure, pulmonary disorder, neurological deficits, and psychiatric symptoms. The main cause of death in NPC1 patients involves central nervous system (CNS) dysfunction; there is no essential treatment. We generated a tyrosine-mutant adeno-associated virus (AAV) 9/3 vector that expresses human NPC1 under a CMV promotor (AAV-CMV-hNPC1) and injected it into the left lateral ventricle (5 μl) and cisterna magna (10 μl) of Npc1 homo-knockout (Npc1-/-) mice. Each mouse received total 1.35×1011 vector genome on day 4 or 5 of life. AAV-treated Npc1-/- mice (n=11) had an average survival of >28 weeks, while all saline-treated Npc1-/- mice (n=11) and untreated Npc1-/- mice (n=6) died within 16 weeks. Saline-treated and untreated Npc1-/- mice lost body weight from seven weeks until death. However, the average body weight of AAV-treated Npc1-/- mice increased until 15 weeks. AAV-treated Npc1-/- mice also showed a significant improvement in Rotarod test performance. A pathological analysis at 11 weeks showed that cerebellar Purkinje cells were preserved in AAV-treated Npc1-/- mice. In contrast, untreated Npc1-/- mice showed an almost total loss of cerebellar Purkinje cells. Combined injection into both the lateral ventricle and cisterna magna achieved broader delivery of the vector to the CNS, leading to better outcomes than noted in previous reports with injection into the lateral ventricles or veins alone. In AAV-treated Npc1-/- mice, vector genome DNA was detected widely in the CNS and liver. Human NPC1 RNA was detected in the brain, liver, lung, and heart. Accumulated unesterified cholesterol in liver was reduced in the AAV-treated Npc1-/- mice. Our results suggest the feasibility of gene therapy for patients with NPC1.

Gene Therapy in a Mouse Model of Niemann–Pick Disease Type C1

Optimization of systemic AAV9 gene therapy in Niemann-Pick disease type C1 mice

A Novel Small NPC1 Promoter Enhances AAV-Mediated Gene Therapy in Mouse Models of Niemann–Pick Type C1 Disease

A novel strategy for delivering Niemann-Pick type C2 proteins across the blood-brain barrier using the brain endothelial-specific AAV-BR1 virus

Gene therapy corrects the neurological deficits of mice with sialidosis

Neurodegeneration in Niemann-Pick type C disease mice

Mutant induced neurons and humanized mice enable identification of Niemann-Pick type C1 proteostatic therapies

Abnormal gene expression in cerebellum of Npc1−/− mice during postnatal development

Differently increased volumes of multiple brain areas in Npc1 mutant mice following various drug treatments

Myeloid cell–specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease

Systemic gene therapy corrects the neurological phenotype in a mouse model of NGLY1 deficiency

Decreased Estradiol Release from Astrocytes Contributes to the Neurodegeneration in a Mouse Model of Niemann‐Pick Disease Type C

Decreased Purinergic Inhibition of Synaptic Activity in a Mouse Model of Niemann‐Pick Disease Type C

New Cellular Models for Niemann–Pick Type C Disease

An in vitro and in vivo efficacy evaluation of a novel gene therapy candidate (SBT101) in mouse models of adrenomyeloneuropathy and in NHPs

Systemic gene therapy using an AAV44.9 vector rescues a neonatal lethal mouse model of propionic acidemia

Liver-Directed Neonatal Gene Therapy Prevents Cardiac, Bone, Ear, and Eye Disease in Mucopolysaccharidosis I Mice

Conditioned medium of human menstrual blood-derived endometrial stem cells protects against cell inflammation and apoptosis of Npc1KO N2a cells

Increased NPC1 mRNA in skin fibroblasts from Niemann-Pick disease type C patients.

Gene therapy restores mitochondrial function and protects retinal ganglion cells in optic neuropathy induced by a mito-targeted mutant ND1 gene

Cerebellar Long-term Depression is Deficient in Niemann–Pick Type C Disease Mice